SEC Form 4 · accession 0001144204-18-035214

PHIBRO ANIMAL HEALTH CORP · PAHC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

10% Owner

Period of report

Jun 19, 2018

Accepted (ET)

Jun 21, 2018 · 9:05 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001069899

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock^F1,F2	Jun 19, 2018	C	30,000	$0.00	A	60,000	D
Class A Common Stock^F2,F3	Jun 19, 2018	S	10,000	$47.35	D	50,000	D
Class A Common Stock^F2,F4	Jun 20, 2018	S	10,000	$47.72	D	40,000	D
Class A Common Stock^F2,F5	Jun 21, 2018	S	9,900	$47.60	D	30,100	D
Class A Common Stock^F2	Jun 21, 2018	S	100	$48.05	D	30,000	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Class B Common Stock^F1,F2	$0.00	Jun 19, 2018	C	30,000	D	—	—	Class A Common Stock	30,000	20,395,504	D

F1Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date.
F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.10 to $47.75, inclusive.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.45 to $48.03, inclusive.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.00 to $47.98, inclusive.